BackTevogen Bio Holdings - Warrants (14/02/2029) Overview

Tevogen Bio Holdings - Warrants (14/02/2029) Total Current Liabilities

Tevogen Bio Holdings - Warrants (14/02/2029)'s total current liabilities is $6.2M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$6.15M
23.90% YoYΔ $-1.93M vs prior year quarter

Peer trimmed avg / median

Loading

Tevogen Bio Holdings - Warrants (14/02/2029) Total Current Liabilities History

Loading

Tevogen Bio Holdings - Warrants (14/02/2029) vs. peers: Total Current Liabilities Comparison

Loading

Tevogen Bio Holdings - Warrants (14/02/2029) Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Tevogen Bio Holdings - Warrants (14/02/2029) (TVGNW) FAQ

The latest total current liabilities for TVGNW is $6.2M as of June 2026. That compares with $8.1M in the prior-year period — down 23.9% year over year. Investors often review this figure alongside Tevogen Bio Holdings - Warrants (14/02/2029)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, TVGNW's total current liabilities moved from $8.1M to $6.2M — a 23.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Tevogen Bio Holdings - Warrants (14/02/2029)'s operating scale or balance-sheet position.

A total current liabilities figure of $6.2M for TVGNW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting TVGNW's total current liabilities ($6.2M), review year-over-year change from $8.1M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.